Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.
Journal
European journal of endocrinology
ISSN: 1479-683X
Titre abrégé: Eur J Endocrinol
Pays: England
ID NLM: 9423848
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
21
09
2020
accepted:
12
01
2021
pubmed:
15
1
2021
medline:
23
2
2021
entrez:
14
1
2021
Statut:
ppublish
Résumé
Corticotroph tumor progression (CTP) leading to Nelson's syndrome (NS) is a severe and difficult-to-treat complication subsequent to bilateral adrenalectomy (BADX) for Cushing's disease. Its characteristics are not well described, and consensus recommendations for diagnosis and treatment are missing. A systematic literature search was performed focusing on clinical studies and case series (≥5 patients). Definition, cumulative incidence, treatment and long-term outcomes of CTP/NS after BADX were analyzed using descriptive statistics. The results were presented and discussed at an interdisciplinary consensus workshop attended by international pituitary experts in Munich on October 28, 2018. Data covered definition and cumulative incidence (34 studies, 1275 patients), surgical outcome (12 studies, 187 patients), outcome of radiation therapy (21 studies, 273 patients), and medical therapy (15 studies, 72 patients). We endorse the definition of CTP-BADX/NS as radiological progression or new detection of a pituitary tumor on thin-section MRI. We recommend surveillance by MRI after 3 months and every 12 months for the first 3 years after BADX. Subsequently, we suggest clinical evaluation every 12 months and MRI at increasing intervals every 2-4 years (depending on ACTH and clinical parameters). We recommend pituitary surgery as first-line therapy in patients with CTP-BADX/NS. Surgery should be performed before extrasellar expansion of the tumor to obtain complete and long-term remission. Conventional radiotherapy or stereotactic radiosurgery should be utilized as second-line treatment for remnant tumor tissue showing extrasellar extension.
Sections du résumé
BACKGROUND
BACKGROUND
Corticotroph tumor progression (CTP) leading to Nelson's syndrome (NS) is a severe and difficult-to-treat complication subsequent to bilateral adrenalectomy (BADX) for Cushing's disease. Its characteristics are not well described, and consensus recommendations for diagnosis and treatment are missing.
METHODS
METHODS
A systematic literature search was performed focusing on clinical studies and case series (≥5 patients). Definition, cumulative incidence, treatment and long-term outcomes of CTP/NS after BADX were analyzed using descriptive statistics. The results were presented and discussed at an interdisciplinary consensus workshop attended by international pituitary experts in Munich on October 28, 2018.
RESULTS
RESULTS
Data covered definition and cumulative incidence (34 studies, 1275 patients), surgical outcome (12 studies, 187 patients), outcome of radiation therapy (21 studies, 273 patients), and medical therapy (15 studies, 72 patients).
CONCLUSIONS
CONCLUSIONS
We endorse the definition of CTP-BADX/NS as radiological progression or new detection of a pituitary tumor on thin-section MRI. We recommend surveillance by MRI after 3 months and every 12 months for the first 3 years after BADX. Subsequently, we suggest clinical evaluation every 12 months and MRI at increasing intervals every 2-4 years (depending on ACTH and clinical parameters). We recommend pituitary surgery as first-line therapy in patients with CTP-BADX/NS. Surgery should be performed before extrasellar expansion of the tumor to obtain complete and long-term remission. Conventional radiotherapy or stereotactic radiosurgery should be utilized as second-line treatment for remnant tumor tissue showing extrasellar extension.
Identifiants
pubmed: 33444221
doi: 10.1530/EJE-20-1088
pii: EJE-20-1088
pmc: PMC8060870
mid: NIHMS1687204
doi:
pii:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
P1-P16Subventions
Organisme : BLRD VA
ID : I01 BX004681
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL144847
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM115428
Pays : United States
Références
Postgrad Med J. 1996 Jan;72(843):53-4
pubmed: 8746287
Biomed Pharmacother. 2000 Jun;54 Suppl 1:140s-145s
pubmed: 10915011
Arch Intern Med. 1978 Apr;138(4):575-9
pubmed: 637638
Clin Endocrinol (Oxf). 1998 Oct;49(4):533-9
pubmed: 9876353
J Clin Endocrinol Metab. 2011 Apr;96(4):E658-62
pubmed: 21289243
Clin Endocrinol (Oxf). 1989 Sep;31(3):309-23
pubmed: 2559823
Neurosurgery. 2018 Sep 1;83(3):430-436
pubmed: 28950324
Eur J Endocrinol. 2013 Mar 20;168(4):639-48
pubmed: 23371975
PLoS One. 2015 Aug 28;10(8):e0135975
pubmed: 26317782
J Neurosurg. 2005 Nov;103(5):825-30
pubmed: 16304985
J Clin Endocrinol Metab. 2007 Jan;92(1):172-9
pubmed: 17062771
Neurosurg Focus. 2003 May 15;14(5):e12
pubmed: 15669808
Pituitary. 2018 Apr;21(2):183-193
pubmed: 29344907
J Neurosurg. 2013 Dec;119(6):1493-7
pubmed: 23952749
J Clin Neurosci. 2014 Sep;21(9):1520-4
pubmed: 24825407
Clin Endocrinol (Oxf). 1993 Sep;39(3):315-21
pubmed: 8222294
Int J Endocrinol. 2015;2015:587893
pubmed: 26106414
Best Pract Res Clin Endocrinol Metab. 2019 Apr;33(2):101270
pubmed: 31036383
J Clin Endocrinol Metab. 1994 Sep;79(3):887-9
pubmed: 8077377
J Clin Endocrinol Metab. 2007 May;92(5):1758-63
pubmed: 17311852
Pituitary. 2006;9(2):151-4
pubmed: 16845600
Acta Neurochir (Wien). 1976;35(1-3):27-42
pubmed: 183463
Eur J Endocrinol. 2009 Jan;160(1):115-9
pubmed: 18984772
Eur J Endocrinol. 2014 Aug;171(2):209-15
pubmed: 24975318
BMJ. 2008 Apr 26;336(7650):924-6
pubmed: 18436948
Endocr Pathol. 2010 Dec;21(4):227-9
pubmed: 21061089
Int J Radiat Oncol Biol Phys. 1988 Nov;15(5):1103-10
pubmed: 3182342
Neurosurgery. 2006 Aug;59(2):341-53; discussion 341-53
pubmed: 16883174
Pituitary. 2020 Jun;23(3):203-211
pubmed: 31875276
Surgery. 1994 Dec;116(6):1088-93; discussion 1093-4
pubmed: 7985092
J Endocrinol Invest. 1978 Oct;1(4):355-7
pubmed: 229153
J Neurosurg. 2007 Jun;106(6):988-93
pubmed: 17564169
J Clin Endocrinol Metab. 1996 Jul;81(7):2647-52
pubmed: 8675592
Clin Endocrinol (Oxf). 1988 Feb;28(2):195-204
pubmed: 2844446
Cancer. 2006 Sep 15;107(6):1355-64
pubmed: 16894526
J Clin Endocrinol Metab. 2008 Feb;93(2):393-9
pubmed: 18029460
Zentralbl Neurochir. 2006 Feb;67(1):14-20
pubmed: 16518746
Neurosurgery. 1993 Oct;33(4):610-7; discussion 617-8
pubmed: 8232800
Endokrynol Pol. 2015;66(6):504-13
pubmed: 26662649
Am J Clin Oncol. 1991 Feb;14(1):25-9
pubmed: 1987733
Arch Endocrinol Metab. 2019 Jun 27;63(5):470-477
pubmed: 31271574
J Pediatr. 1979 Aug;95(2):214-9
pubmed: 448561
Nat Genet. 2015 Jan;47(1):31-8
pubmed: 25485838
J Clin Endocrinol Metab. 2002 Dec;87(12):5465-9
pubmed: 12466338
Case Rep Endocrinol. 2015;2015:623092
pubmed: 26221547
Surgery. 2007 Feb;141(2):147-51; discussion 151-2
pubmed: 17263968
Surgery. 1984 Dec;96(6):1067-77
pubmed: 6505960
World J Surg. 1984 Jun;8(3):374-87
pubmed: 6087575
J Endocr Soc. 2019 Feb 20;3(4):763-772
pubmed: 30963134
J Endocr Soc. 2017 Feb 01;1(2):144-148
pubmed: 29264473
J Endocrinol Invest. 2005 Oct;28(9):795-801
pubmed: 16370557
Chin Med J (Engl). 2002 Aug;115(8):1150-2
pubmed: 12215280
JAMA. 1976 May 24;235(21):2307-10
pubmed: 946623
J Neurosurg. 1985 Jan;62(1):68-71
pubmed: 2981103
Eur J Endocrinol. 2015 Jun;172(6):R227-39
pubmed: 25599709
Endocrine. 2020 Nov;70(2):218-231
pubmed: 32743767
Eur J Endocrinol. 2018 Jan;178(1):57-63
pubmed: 28982703
Q J Med. 1983 Spring;52(206):224-31
pubmed: 6310673
Clin Endocrinol (Oxf). 1983 Dec;19(6):693-8
pubmed: 6317234
J Endocrinol Invest. 1994 Feb;17(2):135-9
pubmed: 8006335
World J Surg. 2000 Jan;24(1):108-13
pubmed: 10594213
J Assoc Physicians India. 1994 Apr;42(4):304-5
pubmed: 7860549
J Neurosurg. 2017 Dec;127(6):1277-1287
pubmed: 28084914
Pituitary. 2016 Dec;19(6):612-624
pubmed: 27678103
N Engl J Med. 1958 Jul 24;259(4):161-4
pubmed: 13566440
Eur J Endocrinol. 2011 Apr;164(4):505-12
pubmed: 21252174
J Clin Endocrinol Metab. 1997 Feb;82(2):514-7
pubmed: 9024246
Endocrinol Jpn. 1981 Apr;28(2):197-205
pubmed: 6273138
Endocr Pract. 2016 Apr;22(4):466-75
pubmed: 26789343
Proc R Soc Med. 1957 Mar;50(3):161-4
pubmed: 13420156
Neurosurg Rev. 1985;8(3-4):185-94
pubmed: 2993956
Acta Neurochir (Wien). 1982;65(1-2):3-13
pubmed: 6291340
Pituitary. 2018 Jun;21(3):247-255
pubmed: 29313180
Bull Los Angeles Neurol Soc. 1977;42(3-4):175-89
pubmed: 227502
Clin Neuropathol. 2009 Nov-Dec;28(6):430-9
pubmed: 19919817
J Clin Endocrinol Metab. 1995 Jan;80(1):165-71
pubmed: 7829606
Ann Surg. 2007 May;245(5):790-4
pubmed: 17457173
Lancet. 1976 Aug 21;2(7982):426
pubmed: 73893
Acta Endocrinol (Copenh). 1989 Jun;120(6):760-6
pubmed: 2543178
J Clin Endocrinol Metab. 1976 Nov;43(5):1179-82
pubmed: 186479
Clin Endocrinol (Oxf). 1990 Oct;33(4):445-55
pubmed: 2225489
Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):208-215
pubmed: 32838436
Eur J Endocrinol. 2009 Feb;160(2):143-8
pubmed: 18996962
J Clin Endocrinol Metab. 1959 Dec;19:1523-39
pubmed: 14440922
Eur J Endocrinol. 2018 Jan;178(1):G1-G24
pubmed: 29046323
J Clin Endocrinol Metab. 2012 May;97(5):E802-4
pubmed: 22563116
Pituitary. 2015 Jun;18(3):376-84
pubmed: 25008022
Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):839-41
pubmed: 12377337
Neuro Endocrinol Lett. 2005 Dec;26(6):709-12
pubmed: 16380696
Arch Intern Med. 2010 Sep 13;170(16):1499-500
pubmed: 20837838
J Clin Endocrinol Metab. 2020 May 1;105(5):
pubmed: 31735971
Am J Dis Child. 1977 Dec;131(12):1353-6
pubmed: 930887
Br Med J. 1976 Jul 31;2(6030):269-72
pubmed: 182313
J Clin Endocrinol Metab. 1976 Jun;42(6):1145-8
pubmed: 6486
Ann Intern Med. 1976 Dec;85(6):731-4
pubmed: 999109
Eur J Endocrinol. 2016 Feb;174(2):213-26
pubmed: 26578638
Ann Surg. 1972 Jun;175(6):948-55
pubmed: 5029845
Clin Neurosurg. 1980;27:19-30
pubmed: 7273554
Clin Endocrinol (Oxf). 2001 Jan;54(1):45-52
pubmed: 11167925
Eur J Surg. 1991 Aug;157(8):461-4
pubmed: 1681932
N Engl J Med. 1971 Jul 29;285(5):243-7
pubmed: 4326256
Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):532-9
pubmed: 25194666
Cleve Clin Q. 1980 Winter;47(4):299-304
pubmed: 7471463
Clin Endocrinol (Oxf). 1983 Mar;18(3):301-5
pubmed: 6305539
Indian J Endocrinol Metab. 2015 Nov-Dec;19(6):834-40
pubmed: 26693437
Eur J Endocrinol. 2010 Dec;163(6):843-51
pubmed: 20870708
Clin Endocrinol (Oxf). 2006 May;64(5):519-22
pubmed: 16649970